Brand Access Report: Oncology Pathways Landscape

In 2023, stakeholders identified oncologist adherence to pathways as a key priority.

Before developing and launching new pathways, many payers plan to explore methods to build adherence.

Discover the latest insights on oncology pathways and their impact on treatment decisions in the most recent report from NAVLIN Insights. Identify the stakeholders that have the greatest influence on pathway development and the opportunities that exist for biopharma to engage with key customers.

A full report with additional insights is available as part of the NAVLIN Insights subscription. Contact us at for access and to learn more about NAVLIN by EVERSANA and our innovative market research solutions.